Aim: Our goal is to evaluate benzodifuran-based scaffolds for biomedical applications. Methodology: We here explored the anticancer and anti-amyloid activities of a novel compound (BZ4) in comparison with other known benzodifuran analogs, previously studied in our group, and we have explored its ability to interact with different DNA model systems. Results:BZ4 shows antiproliferative activity on different cancer cells; does not affect noncancerous control cells and alters the aggregation properties of β-amyloid, as ascertained by circular dichroism, fluorescence spectroscopy and scanning electron microscopy analysis. An overall, qualitative picture on the mechanistic aspects related to the biological activities is discussed in light of the dynamic light scattering, UV, circular dichroism and fluorescence data, as well as of the metal ion-binding properties of BZ4.

Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound / Vicidomini, Caterina; Cioffi, Federica; Broersen, Kerensa; Roviello, Valentina; Riccardi, Claudia; Montesarchio, Daniela; Capasso, Domenica; Gaetano, Sonia Di; Musumeci, Domenica; Roviello, Giovanni N. - In: FUTURE MEDICINAL CHEMISTRY. - ISSN 1756-8919. - 11:4(2019), pp. 285-302. [10.4155/fmc-2018-0473]

Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound

Roviello, Valentina;Riccardi, Claudia;Montesarchio, Daniela;Capasso, Domenica;Musumeci, Domenica
;
Roviello, Giovanni N
2019

Abstract

Aim: Our goal is to evaluate benzodifuran-based scaffolds for biomedical applications. Methodology: We here explored the anticancer and anti-amyloid activities of a novel compound (BZ4) in comparison with other known benzodifuran analogs, previously studied in our group, and we have explored its ability to interact with different DNA model systems. Results:BZ4 shows antiproliferative activity on different cancer cells; does not affect noncancerous control cells and alters the aggregation properties of β-amyloid, as ascertained by circular dichroism, fluorescence spectroscopy and scanning electron microscopy analysis. An overall, qualitative picture on the mechanistic aspects related to the biological activities is discussed in light of the dynamic light scattering, UV, circular dichroism and fluorescence data, as well as of the metal ion-binding properties of BZ4.
2019
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound / Vicidomini, Caterina; Cioffi, Federica; Broersen, Kerensa; Roviello, Valentina; Riccardi, Claudia; Montesarchio, Daniela; Capasso, Domenica; Gaetano, Sonia Di; Musumeci, Domenica; Roviello, Giovanni N. - In: FUTURE MEDICINAL CHEMISTRY. - ISSN 1756-8919. - 11:4(2019), pp. 285-302. [10.4155/fmc-2018-0473]
File in questo prodotto:
File Dimensione Formato  
fmc-2018-0473.pdf

accesso aperto

Descrizione: Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound
Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 5.43 MB
Formato Adobe PDF
5.43 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/746605
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact